Telomeropathies: rare disease syndromes
Journal Title: Medical Science Pulse - Year 2018, Vol 12, Issue 2
Abstract
Telomeres are located at the end of the chromosomes. They protect chromosomes from fusion and degradation. Every cell division causes a shortening of the telomeres. A special enzymatic complex called telomerase is responsible for maintaining telomere length in intensively dividing cells, such as epithelial cells and bone marrow cells. The enzymatic complex includes the TERT subunit, which has reverse transcriptase activity, and the TERC subunit, which acts as a template. Other important components of telomerase are the proteins that are responsible for structural stability. Telomerase remains active only in the dividing cells of the body. The rate of telomere shortening depends on many factors including age, sex, and comorbidities. Faster shortening of telomeres is caused by gene defects, which have an impact on telomerase action. Collectively, these are called telomeropathies. Common causes of telomeropathies are mutations in the TERT and TERC telomerase genes. Types of telemeropathies include dyskeratosis congenita, idiopathic pulmonary fibrosis, and aplastic anaemia, among others. Clinical manifestations and prognoses depend on the type and quantity of mutated genes. Diagnosis of telomeropathies is often problematic because they present with the same symptoms as other diseases. So far, no effective therapeutic methods have been developed for telomeropathies. A therapeutic method for patients with bone marrow failure may be the transplantation of hematopoietic stem cells. For patients with idiopathic pulmonary fibrosis, treatments include immunosuppressive therapy, lung transplantation, or palliative care. In the future, gene therapy may be an effective treatment strategy for telomeropathies. Lifestyle changes may also have a positive impact on the person. Physical activity combined with a healthy diet rich in antioxidants and unsaturated fatty acids can decrease the oxidative stress levels in cells and lead to a slower shortening of the telomeres.<br/><br/>
Authors and Affiliations
Anna Pańczyszyn, Ewa Boniewska-Bernacka
Keywords
Related Articles
- EP ID EP346765
- DOI 10.5604/01.3001.0012.1165
- Views 143
- Downloads 0
Jakość życia chorych na stwardnienie rozsiane
Wstęp: W badaniach oceniających jakość życia chorych na stwardnienie rozsiane (MS) poszukuje się odpowiedzi na pytanie, które wymiary jakości życia są najbardziej obniżone na skutek choroby. Szeroko rozumiana jakość życi...
Can physical training minimize the gender differences in lung capacity of trained tennis players aged 14 – 17 years old ?
Background: This study was based on gender differences in male and female trained tennis players. Aim of the study: The aim of this study was to determine the extent that physical training could minimize the gender diffe...
Depressive disorders – the nurse’s role in the education of the patient and his family
Background: Depression is a chronic, relapsing disease. Disorder is not only physical and mental state of man, but also its function in society. Patients and their families often have a lack of knowledge about the diseas...
Projekty rozwojowe bibliotek akademickich w zakresie udostępniania e-zasobów naukowych finansowane ze środków krajowych i unijnych
Biblioteki naukowe szkół wyższych są zainteresowane transformacją tradycyjnych zasobów naukowych w formie drukowanej na ich elektroniczne odpowiedniki, udostępnianew miarę możliwości w wolnym dostępie poprzez sieć intern...
Arrhythmogenic right ventricular cardiomyopathy – step by step diagnosis
Background: The arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare and genetically determined heart disease. Its first manifestation might be a sudden cardiac death which usually affects young and apparentl...